Investigative Ophthalmology & Visual Science Cover Image for Volume 64, Issue 8
June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Identification of novel genes and isoforms expressed in human retina and retinal pigment epithelium using the new T2T-CHM13 human genome assembly
Author Affiliations & Notes
  • Sudeep Mehrotra
    Ocular Genomic Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ayellet V. Segre
    Ocular Genomic Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Kinga Maria Bujakowska
    Ocular Genomic Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Eric A Pierce
    Ocular Genomic Institute, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Sudeep Mehrotra None; Ayellet Segre None; Kinga Bujakowska None; Eric Pierce None
  • Footnotes
    Support  NIH R01EY012910 (EAP), NIH EY020902 (EAP), NEI R01EY026904 (KMB/EAP), Foundation Fighting Blindness, P30EY014104 (MEEI core support), NIH/NEI R01 EY031424 (AVS)
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 1856. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sudeep Mehrotra, Ayellet V. Segre, Kinga Maria Bujakowska, Eric A Pierce; Identification of novel genes and isoforms expressed in human retina and retinal pigment epithelium using the new T2T-CHM13 human genome assembly. Invest. Ophthalmol. Vis. Sci. 2023;64(8):1856.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The genetic causes of inherited retinal degenerations (IRDs) remain elusive in many patients. This may in part be due to the missing genetic information of unresolved regions in the current human reference genome (GRCh38). Using ultra-long DNA reads in combination with short sequencing technology, the Telomere-to-Telomere (T2T) Consortium has provided gapless human haploid genome assembly using CHM13hTERT cell line. In this new reference genome assembly, there are 3,604 gene exclusive to the T2T-CHM13 genome. To understand the relevance of these genes to retinal disease, we reanalyzed RNA-sequencing (RNA-Seq) data of non-diseased human retina and retinal pigment epithelium (RPE) using the T2T-CHM13 genome.

Methods : We re-analyzed and mapped short-read RNA-Seq data from previously published 131 human healthy donor retina (macular and peripheral) and 36 RPE (including macular, peripheral RPE/choroid/sclera) samples obtained from non-diseased eyes to the T2T-CHM13 genome. We also included PacBio HiFi long-reads RNA-seq data from 4 healthy retinas samples. For short reads sequencing, the STAR aligner was used to align stranded, PE reads and the featureCount was used to quantify gene expression. For HiFi reads, the Iso-Seq pipeline from PacBio was used to obtain high quality isoform reads. A standard SQANTI3 workflow was used for isoform identification and classification. StringTie2 was used to merge individual transcripts to create a non-redundant gene model set.

Results : Short-read RNA-Seq identified 36,997 expressed genes in RPE and retina. Furthermore, 500 genes (unique union of RPE and retina) fell into T2T-CHM13 exclusive regions of the genome. Based on liftovers and close paralogs between CHM13 and GRCh38 biotype annotations, ~43% of the newly discovered genes in retina and RPE are lncRNA, 22% processed_pseudogene, about 8% protein coding among others. Long-read sequencing identified 229,882 total transcripts including 42,339 novel transcripts. In the T2T-CHM13 exclusive regions we detected expression of 407 of the 500 genes identified to be expressed by the short-read data.

Conclusions : These analyses identified expression of 500 genes located in the T2T-CHM13 exclusive regions of the genome in the retina and RPE. Future exploration of these novel T2T-CHM13 genes and transcripts may be help uncover part of the missing genetic causality of IRDs.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×